NewsBenzingaBeam Therapeutics T3 BPA de $(1,28) no alcanza la estimación de $(1,15), ventas de $307.000K no alcanzan la estimación de $8,752M Beam Therapeutics T3 BPA de $(1,28) no alcanza la estimación de $(1,15), ventas de $307.000K no alcanzan la estimación de $8,752M Benzinga 2026.11.03 12:08 (GMT+0) Open on Benzinga Other news Israeli Shipping Giant ZIM Cashes In on Surging Freight Rates, Raises Outlook UBS Maintains Buy on Home Depot, Lowers Price Target to $417 Disney Posts Upbeat Q4, Analysts Raise Price Target Citing Theme Park Resilience StoneX Maintains Buy on Bitdeer Techs, Lowers Price Target to $15 Merck Pulls Plug On Acquired Drug after Safety Review UBS Maintains Neutral on Granite Point Mortgage Tr, Lowers Price Target to $3